Samsung Medical Center: Depression trials

The registry lists 11 Depression studies with Samsung Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Individualized Automatic Coaching Message for Glycemic Management and Depressive SymptomNot yet recruitingNCT06684678Not applicable
• Effectiveness of Individualized Automatic Coaching Message for Glycemic Management and Depressive SymptomCompletedNCT06769906Not applicable
• Individualized Automatic Target Coaching Message for Glycemic Management and Depressive SymptomCompletedNCT06525454Not applicable
• Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid NeuroimagingStatus unknownNCT02983838
• Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed PatientsStatus unknownNCT01352572Not applicable
• Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic PhenotypeStatus unknownNCT01352559Not applicable
• Comparison of Tianeptine Versus Escitalopram Patients Major Depressive DisorderCompletedNCT01309776Phase 4
• Predict Antidepressant Responsiveness Using PharmacogenomicsStatus unknownNCT01228357Not applicable
• Pharmacogenetic Study of Mirtazapine Response in Depressed PatientsStatus unknownNCT01039740Not applicable
• Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed PatientsStatus unknownNCT00817375Not applicable
• Development of Pharmacogenomic Method to Predict Antidepressant ResponsivenessStatus unknownNCT00817011Not applicable